John Allan, MD
Associate Professor of Clinical Medicine
Division of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York
John Allan, MD, has disclosed that he has received consulting fees from AbbVie, ADC Therapeutics, BeiGene, Epizyme, Genentech, Janssen, Pharmacyclics, and TG Therapeutics; funds for research support from Genentech, Janssen, and TG Therapeutics; and fees for non-CME/CE services from AbbVie, BeiGene, Janssen, and Pharmacyclics.
Sandra E. Kurtin, PhD, ANP-C, AOCN
Director, Advanced Practice and Clinical Integration
The University of Arizona Cancer Center
Assistant Professor, Clinical Medicine
Adjunct Clinical Professor, Nursing
The University of Arizona
Sandra E. Kurtin, PhD, ANP-C, AOCN, has disclosed that she has received consulting fees from AbbVie, Amgen, Bristol-Myers Squibb, Epizyme, Incyte, and Pharmacyclics.